Broad modulation of tissue responses (Immune Activation) by celacade may favorably influence pathologic processes associated with heart failure progression

American Journal of Cardiology

Volumn 95, Issue 11 SUPPL. 1, 2005, Pages 30-37

  Torre Amione, Guillermo ^a   Sestier, François ^b   Radovancevic, Branislav ^b   Young, James ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE CLASSIFICATION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOMODULATION; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; MALE; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SAMPLE SIZE; STANDARDIZATION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; WALKING;

EID: 19944399819     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.03.010     Document Type: Conference Paper

References (32)

1. S. Hegewisch, H.J. Weh, D.K. Hossfeld TNF-induced cardiomyopathy Lancet 1990 335 294-295
2. M.S. Finkel, C.V. Oddis, T.D. Jacob, S.C. Watkins, B.G. Hattler, R.L. Simmons Negative inotropic effects of cytokines on the heart mediated by nitric oxide Science 257 1992 387 389
3. F.D. Pagani, L.S. Baker, C. Hsi, M. Knox, M.P. Fink, M.S. Visner Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs J Clin Invest 90 1992 389 398
4. M.B. Fowler, J.A. Laser, G.L. Hopkins, W. Minobe, M.R. Bristow Assessment of the beta-adrenergic receptor pathway in the intact failing human heart progressive receptor down-regulation and subsensitivity to agonist response Circulation 74 1986 1290 1302
5. A. Blum, H. Miller Role of cytokines in heart failure Am Heart J 135 1998 181 186
6. E.S. Chung, M. Packer, K.H. Lo, A.A. Fasanmade, J.T. Willerson for the Anti-TNF Therapy Against Congestive Heart Failure Investigators Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial Circulation 107 2003 3133 3140
7. D.L. Mann, J.J. McMurray, M. Packer, K. Swedberg, J.S. Borer, W.S. Colucci, J. Djian, H. Drexler, A. Feldman, L. Kober Targeted anticytokine therapy in patients with chronic heart failure results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) Circulation 109 2004 1594 1602
8. D.L. Mann, J.B. Young Basic mechanisms in congestive heart failure recognizing the role of proinflammatory cytokines Chest 105 1994 897 904
9. J.E. Parrillo, R.E. Cunnion, S.E. Epstein, M.M. Parker, A.F. Suffredini, M. Brenner, G.L. Schaer, S.T. Palmeri, R.O. Cannon III, D. Alling A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy N Engl J Med 32 1989 1061 1068
10. L. Gullestad, H. Aass, J.G. Fjeld, L. Wikeby, A.K. Andreassen, H. Ihlen, S. Simonsen, J. Kjekshus, S. Nitter-Hauge, T. Ueland Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure Circulation 103 2001 220 225
11. A. Staudt, F. Schaper, V. Stangl, A. Plagemann, M. Bohm, K. Merkel, G. Wallukat, K.D. Wernecke, K. Stangl, G. Baumann, S.B. Felix Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution Circulation 103 2001 2681 2686
12. S. Babaei, D.J. Stewart, P. Picard, J.C. Monge Effects of VasoCare therapy on the initiation and progression of atherosclerosis Atherosclerosis 162 2002 45 53
13. G.M. Shivji, H. Suzuki, A.S. Mandel, A.E. Bolton, D.N. Sauder The effect of VAS972 on allergic contact hypersensitivity J Cutan Med Surg 4 2000 132 137
14. Y. Nolan, A. Minogue, E. Vereker, A.E. Bolton, V.A. Campbell, M.A. Lynch Attenuation of LPS-induced changes in synaptic activity in rat hippocampus by Vasogen's Immune Modulation Therapy Neuroimmunomodulation 10 2002 40 46
15. L.I. Edvinsson, M.L. Edvinsson, G. Angus Deveber Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease Int Angiol 22 2003 141 147
16. C. McGrath, R. Robb, A.J. Lucas, A.H. Stewart, C.L. Underwood, J.K. Horridge, P.M. Lamont, F.C. Smith, R.N. Baird A randomised, double blind, placebo-controlled study to determine the efficacy of immune modulation therapy in the treatment of patients suffering from peripheral arterial occlusive disease with intermittent claudication Eur J Vasc Endovasc Surg 23 2002 381 387
17. M. Packer Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure J Card Fail 7 2001 176 182
18. G. Torre-Amione, F. Sestier, B. Radovancevic, J. Young Effects of a novel immune modulation therapy in patients with advanced chronic heart failure results of a randomized, controlled, phase 2 trial J Am Coll Cardiol 44 2004 1181 1186
19. M. Packer, C.M. O'Connor, J.K. Ghali, M.L. Pressler, P.E. Carson, R.N. Belkin, A.B. Miller, G.W. Neuberg, D. Frid, J.H. Wertheimer for the Prospective Randomized Amlodipine Survival Evaluation Study Group Effect of amlodipine on morbidity and mortality in severe chronic heart failure N Engl J Med 335 1996 1107 1114
20. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, J. Wittes for the Randomized Aldactone Evaluation Study Investigators The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709 717
21. C. Torp-Pedersen, M. Moller, P.E. Bloch-Thomsen, L. Kober, E. Sandoe, K. Egstrup, E. Agner, J. Carlsen, J. Videbaek, B. Marchant, A.J. Camm for the Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group Dofetilide in patients with congestive heart failure and left ventricular dysfunction N Engl J Med 341 1999 857 865
22. R.S. McKelvie, S. Yusuf, D. Pericak, A. Avezum, R.J. Burns, J. Probstfield, R.T. Tsuyuki, M. White, J. Rouleau, R. Latini for The RESOLVD Pilot Study Investigators Comparison of candesartan, enalapril, and their combination in congestive heart failure randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study Circulation 100 1999 1056 1064
23. L. Klein, C.M. O'Connor, W.A. Gattis, M. Zampino, L. de Luca, A. Vitarelli, F. Fedele, M. Gheorghiade Pharmacologic therapy for patients with chronic heart failure and reduced systolic function review of trials and practical considerations Am J Cardiol 91 suppl 2003 18F 40F
24. V.A. Fadok, D.L. Bratton, A. Konowal, P.W. Freed, J.Y. Westcott, P.M. Henson Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF J Clin Invest 101 1998 890 898
25. G. Torre-Amione, K. Becker, R.J. Ray, S.E. Bolton, D.L. Mann Attenuation of myocardial inflammation by Celacade (immune modulation therapy) in murine model of myosin-induced myocarditis J Card Fail 10 suppl 2004 S49 Abstract 115
26. A. Gradman, P. Deedwania, R. Cody, B. Massie, M. Packer, B. Pitt, S. Goldstein for the Captopril-Digoxin Study Group Predictors of total mortality and sudden death in mild to moderate heart failure J Am Coll Cardiol 14 1989 564 570
27. G. Alloatti, C. Penna, A. De Martino, G. Montrucchio, G. Camussi Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle Cardiovasc Res 41 1999 611 619
28. G.F. Tomaselli, E. Marban Electrophysiological remodeling in hypertrophy and heart failure Cardiovasc Res 42 1999 270 283
29. G.F. Tomaselli, D.J. Beuckelmann, H.G. Calkins, R.D. Berger, P.D. Kessler, J.H. Lawrence, D. Kass, A.M. Feldman, E. Marban Sudden cardiac death in heart failure the role of abnormal repolarization Circulation 90 1994 2534 2539
30. A.D. Wickenden, R. Kaprielian, Z. Kassiri, J.N. Tsoporis, R. Tsushima, G.I. Fishman, P.H. Backx The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure Cardiovasc Res 37 1998 312 323
31. c interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide Circulation 103 2001 1422 1427
32. J.D. Harding, V. Piacentino III, J.P. Gaughan, S.R. Houser, K.B. Margulies Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure Circulation 104 2001 1241 1247